Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer: a systematic review
出版年份 2021 全文链接
标题
Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer: a systematic review
作者
关键词
-
出版物
BREAST CANCER RESEARCH AND TREATMENT
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-05-27
DOI
10.1007/s10549-021-06259-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Delineating the breast cancer immune microenvironment in the era of multiplex immunohistochemistry/immunofluorescence (mIHC/IF)
- (2021) Tracy Zhijun Tien et al. HISTOPATHOLOGY
- Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis
- (2020) Guoxuan Gao et al. BMC CANCER
- Histologic subtyping affecting outcome of triple negative breast cancer: a large Sardinian population-based analysis
- (2020) Francesca Sanges et al. BMC CANCER
- How to treat lobular cancer in the adjuvant setting?
- (2020) Dario Trapani et al. CURRENT OPINION IN ONCOLOGY
- Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies
- (2020) Antonio Marra et al. npj Breast Cancer
- Clinicopathological characteristics and prognosis of breast cancer with special histological types: A surveillance, epidemiology, and end results database analysis
- (2020) Yiqun Han et al. BREAST
- Clinical outcomes and patterns of care in the treatment of carcinosarcoma of the breast
- (2019) William R. Kennedy et al. Cancer Medicine
- HER2+ and triple-negative phenotypes in invasive lobular carcinoma might have different specific biological features
- (2019) Kadri Altundag BREAST CANCER RESEARCH AND TREATMENT
- Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2019) F Cardoso et al. ANNALS OF ONCOLOGY
- ICD-11
- (2019) The Lancet LANCET
- Diffuse distribution of tumor-infiltrating lymphocytes is a marker for better prognosis and chemotherapeutic effect in triple-negative breast cancer
- (2019) Akira I. Hida et al. BREAST CANCER RESEARCH AND TREATMENT
- Therapeutic landscape of metaplastic breast cancer
- (2019) N. Tray et al. CANCER TREATMENT REVIEWS
- Predictive and prognostic value of stromal tumour-infiltrating lymphocytes before and after neoadjuvant therapy in triple negative and HER2-positive breast cancer
- (2019) Tomohiro Ochi et al. EUROPEAN JOURNAL OF CANCER
- The fragility of phase 3 trials supporting FDA-approved anticancer medicines: a retrospective analysis
- (2019) Joseph C Del Paggio et al. LANCET ONCOLOGY
- Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019
- (2019) H J Burstein et al. ANNALS OF ONCOLOGY
- Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy
- (2019) J H Park et al. ANNALS OF ONCOLOGY
- Comparison of outcomes between metaplastic and triple-negative breast cancer patients
- (2019) Praveen Polamraju et al. BREAST
- Molecular stratification within triple-negative breast cancer subtypes
- (2019) Dong-Yu Wang et al. Scientific Reports
- Squamous cell carcinoma of the breast: A retrospective study
- (2018) Maher Soliman Journal of Cancer Research and Therapeutics
- Registration in the international prospective register of systematic reviews (PROSPERO) of systematic review protocols was associated with increased review quality
- (2018) Sofia Sideri et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
- (2018) Carsten Denkert et al. LANCET ONCOLOGY
- Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple negative breast cancer patients after neo-adjuvant chemotherapy
- (2018) S J Luen et al. ANNALS OF ONCOLOGY
- Clinicopathological characteristics and prognosis of metaplastic carcinoma of the breast
- (2017) Meng Xiao et al. Oncology Letters
- Pure Apocrine Carcinomas Represent a Clinicopathologically Distinct Androgen Receptor–Positive Subset of Triple-Negative Breast Cancers
- (2016) Anne M. Mills et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Chemotherapy Significantly Improves Survival for Patients with T1c-T2N0M0 Medullary Breast Cancer: 3739 Cases From the National Cancer Data Base
- (2016) Alina M. Mateo et al. ANNALS OF SURGICAL ONCOLOGY
- Prognostic and predictive value of tumor infiltrating lymphocytes in early breast cancer
- (2016) Carmen Criscitiello et al. CANCER TREATMENT REVIEWS
- Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant Setting
- (2016) Luisa Carbognin et al. ONCOLOGIST
- Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer
- (2015) Adnan Aydiner et al. MEDICINE
- Snowballing citations
- (2015) Helen H G Handoll et al. BMJ-British Medical Journal
- Snowballing citations
- (2015) Helen H G Handoll et al. BMJ-British Medical Journal
- Immunoscoring breast cancer: TILs remember what they target
- (2014) G. Curigliano et al. ANNALS OF ONCOLOGY
- Clinicopathologic characteristics and prognosis of primary squamous cell carcinoma of the breast
- (2014) Jing Liu et al. BREAST CANCER RESEARCH AND TREATMENT
- Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study
- (2014) E A Rakha et al. BRITISH JOURNAL OF CANCER
- Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
- (2014) M. D. Burstein et al. CLINICAL CANCER RESEARCH
- Rare Breast Cancer Subtypes: Histological, Molecular, and Clinical Peculiarities
- (2014) M. V. Dieci et al. ONCOLOGIST
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Rare Breast Cancer: 933 Adenoid Cystic Carcinomas from the National Cancer Data Base
- (2013) Nandini Kulkarni et al. ANNALS OF SURGICAL ONCOLOGY
- Tackling the Diversity of Triple-Negative Breast Cancer
- (2013) N. C. Turner et al. CLINICAL CANCER RESEARCH
- Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes
- (2013) Brian D Lehmann et al. JOURNAL OF PATHOLOGY
- The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy: The relationship between the outcome and the clinicopathological characteristics
- (2012) Tomoya Nagao et al. BREAST
- FGFR Signaling Promotes the Growth of Triple-Negative and Basal-Like Breast Cancer Cell Lines Both In Vitro and In Vivo
- (2011) Rachel Sharpe et al. CLINICAL CANCER RESEARCH
- Responses to Liposomal Doxorubicin, Bevacizumab, and Temsirolimus in Metaplastic Carcinoma of the Breast: Biologic Rationale and Implications for Stem-Cell Research in Breast Cancer
- (2011) Stacy Moulder et al. JOURNAL OF CLINICAL ONCOLOGY
- Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers
- (2011) Daniel Wetterskog et al. JOURNAL OF PATHOLOGY
- Impact of Progression During Neoadjuvant Chemotherapy on Surgical Management of Breast Cancer
- (2010) Abigail S. Caudle et al. ANNALS OF SURGICAL ONCOLOGY
- Triple-negative breast cancer: disease entity or title of convenience?
- (2010) Lisa Carey et al. Nature Reviews Clinical Oncology
- Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics
- (2009) B. T. Hennessy et al. CANCER RESEARCH
- Refinement of breast cancer classification by molecular characterization of histological special types
- (2008) B Weigelt et al. JOURNAL OF PATHOLOGY
- Breast cancer special types: why bother?
- (2008) JS Reis-Filho et al. JOURNAL OF PATHOLOGY
- Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum
- (2008) Marick Laé et al. MODERN PATHOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started